![]() |
Testing IDO Inhibitors As A Treatment For Cancer: Preclinical Data Support Ongoing Cl
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors...
More... |
| All times are GMT -7. The time now is 08:13 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021